What are the clinical criteria for Diabetic Ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Diabetic ketoacidosis (DKA) is diagnosed when a patient meets three key clinical criteria: hyperglycemia, ketosis, and metabolic acidosis, with the most recent and highest quality study suggesting criteria of blood glucose >250 mg/dl, pH <7.3, and bicarbonate <18 mEq/l 1.

Clinical Criteria for DKA

The clinical criteria for DKA include:

  • Hyperglycemia: blood glucose level greater than 250 mg/dL
  • Ketosis: presence of ketones in blood or urine
  • Metabolic acidosis: pH less than 7.3 and bicarbonate less than 18 mEq/L Additionally, patients typically present with an anion gap greater than 10-12 mEq/L.

Laboratory Evaluation

Laboratory evaluation should include:

  • Comprehensive metabolic panel
  • Complete blood count
  • Urinalysis
  • Serum ketones (beta-hydroxybutyrate)
  • Arterial or venous blood gas
  • Assessment of precipitating factors such as infection

Pathophysiology

The pathophysiology of DKA involves insulin deficiency leading to increased lipolysis, fatty acid oxidation, and ketone body production, while hyperglycemia results from decreased glucose utilization and increased gluconeogenesis.

Treatment

Prompt recognition of these criteria is essential as DKA is a medical emergency requiring immediate treatment with insulin, fluid resuscitation, and electrolyte replacement, with the most recent study suggesting that there is no significant difference in outcomes for intravenous human regular insulin versus subcutaneous rapid-acting analogs when combined with aggressive fluid management for treating mild or moderate DKA 1.

From the FDA Drug Label

Hyperglycemia, diabetic ketoacidosis, or hyperosmolar coma may develop if the patient takes less Humulin R U-100 than needed to control blood glucose levels Early signs of diabetic ketoacidosis include glycosuria and ketonuria Polydipsia, polyuria, loss of appetite, fatigue, dry skin, abdominal pain, nausea and vomiting and compensatory tachypnea come on gradually, usually over a period of some hours or days, in conjunction with hyperglycemia and ketonemia. The first symptoms of DKA usually come on gradually, over a period of hours or days, and include a drowsy feeling, flushed face, thirst, loss of appetite, and fruity odor on the breath. With DKA, blood and urine tests show large amounts of glucose and ketones.

The clinical criteria for Diabetic Ketoacidosis (DKA) include:

  • Hyperglycemia: high blood glucose levels
  • Ketonuria: presence of ketones in the urine
  • Glycosuria: presence of glucose in the urine
  • Polydipsia: excessive thirst
  • Polyuria: excessive urination
  • Loss of appetite
  • Fatigue
  • Dry skin
  • Abdominal pain
  • Nausea and vomiting
  • Compensatory tachypnea: rapid breathing
  • Drowsy feeling
  • Flushed face
  • Fruity odor on the breath
  • Large amounts of glucose and ketones in blood and urine tests 2 2 2

From the Research

Clinical Criteria for Diabetic Ketoacidosis (DKA)

The clinical criteria for DKA include:

  • Serum glucose level greater than 250 mg per dL 3, 4, 5
  • pH less than 7.3 3, 4, 5
  • Serum bicarbonate level less than 18 mEq per L 3, 4, 5
  • Elevated serum ketone level 3, 4, 5
  • Dehydration 3, 4

Diagnostic Considerations

Other diagnostic considerations for DKA include:

  • Measurement of A1C, blood urea nitrogen, creatinine, serum glucose, electrolytes, pH, and serum ketones 3, 4
  • Complete blood count 3, 4
  • Urinalysis 3, 4
  • Electrocardiography 3, 4
  • Calculation of anion gap and osmolar gap 3, 4

Severity of DKA

The severity of DKA can be classified based on the pH level, with severe cases having a pH ≤ 7.00 6 or ≤ 6.9 6. Very severe DKA in type 2 diabetes is not uncommon and can be managed following standard published or institutional guidelines 6.

Treatment and Management

Treatment for DKA involves:

  • Administering intravenous fluids and insulin 3, 4, 5
  • Monitoring glucose and electrolyte levels 3, 4, 5
  • Replacing electrolytes such as potassium, phosphorous, and magnesium as needed 5
  • Treating precipitating causes such as infection or insulin omission 3, 4, 5
  • Considering bicarbonate therapy in very severe cases, although its use is controversial 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diabetic ketoacidosis: evaluation and treatment.

American family physician, 2013

Research

Diabetic Ketoacidosis: Evaluation and Treatment.

American family physician, 2024

Research

Diabetic ketoacidosis.

American family physician, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.